Provides analytical testing services for food, environment, pharmaceutical, and consumer products. Offers laboratory services, including water, air, and soil testing. Now — the numbers.
This is an established company with proven profits.
No real growth (2% a year).
The gap is $4.2B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 26.2× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
The stock trades 36% below its peak. The market has trimmed its expectations for the company.
It pays out $0.84 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
As the slice kept from each sale thins out, so does the profit. Council score: 3/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.